Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Adaptive Biotechnologies Corporation long term debt for the quarter ending December 31, 2025 were 126.6M, a 4.42% decrease year-over-year.
- Adaptive Biotechnologies Corporation long term debt for 2025 were 126.6M, a 4.42% decrease from 2024.
- Adaptive Biotechnologies Corporation long term debt for 2024 were 132.4M, a 1.34% increase from 2023.
- Adaptive Biotechnologies Corporation long term debt for 2023 were 130.7M, a 4.23% increase from 2022.
- Adaptive Biotechnologies Corporation long term debt for 2022 were 125.4M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adaptive Biotechnologies Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $127 |
| 2024 | $132 |
| 2023 | $131 |
| 2022 | $125 |
| Adaptive Biotechnologies Corporation Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $127 |
| 2024-12-31 | $132 |
| 2023-12-31 | $131 |
| 2022-12-31 | $125 |
Adaptive Biotechnologies Corporation Long Term Debt — FAQ
Adaptive Biotechnologies Corporation (ADPT) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's long term debt history?
The chart and table above show Adaptive Biotechnologies Corporation's long term debt by year and by quarter, including the growth rate.